Amphetamine use disorder Clinical Trials

16 recruitingLast updated: May 29, 2026

There are 16 actively recruiting amphetamine use disorder clinical trials across 5 countries. Studies span Not Applicable, Early Phase 1, Phase 2. Top locations include Lexington, Kentucky, United States, Shanghai, Shanghai Municipality, China, Elâzığ, Elâzığ, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


Amphetamine use disorder Trials at a Glance

16 actively recruiting trials for amphetamine use disorder are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Lexington, Shanghai, and Elâzığ. Lead sponsors running amphetamine use disorder studies include Elazığ Mental Health and Diseases Hospital, Shanghai Mental Health Center, and William Stoops.

Browse amphetamine use disorder trials by phase

Treatments under study

About Amphetamine use disorder Clinical Trials

Looking for clinical trials for Amphetamine use disorder? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Amphetamine use disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Amphetamine use disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii

Methamphetamine Use DisorderContingency Managment
Queen's Medical Center40 enrolled1 locationNCT06532370
Recruiting

ECG Findings in Methamphetamine Use

Methamphetamine Induced PsychosisMethamphetamine Use Disorder
Elazığ Mental Health and Diseases Hospital240 enrolled1 locationNCT07459244
Recruiting
Not Applicable

A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder

Methamphetamine Use Disorder
The University of Texas Health Science Center, Houston20 enrolled1 locationNCT06712446
Recruiting

LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis

Methamphetamine Induced PsychosisMethamphetamine Use Disorder
Elazığ Mental Health and Diseases Hospital120 enrolled1 locationNCT07450027
Recruiting
Phase 2

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

methamphetamine abuseSubstance AbuseMethamphetamine Dependence+2 more
Centre hospitalier de l'Université de Montréal (CHUM)80 enrolled1 locationNCT06788587
Recruiting
Not Applicable

Non-Abstinence Outcomes in Methamphetamine Use Disorder

Methamphetamine Use Disorder
William Stoops300 enrolled1 locationNCT07226596
Recruiting
Early Phase 1

Methamphetamine and Troriluzole

Methamphetamine Use Disorder
William Stoops40 enrolled1 locationNCT06989853
Recruiting
Not Applicable

Paired-pulse rTMS Treatment for Methamphetamine Use Disorder Based on the mPFC-Cerebellum

Methamphetamine Use Disorder
Shanghai Mental Health Center70 enrolled1 locationNCT06457230
Recruiting
Not Applicable

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

HIVMethamphetamine Use Disorders
Gopalkumar Rakesh30 enrolled1 locationNCT06830980
Recruiting
Early Phase 1

Psilocybin for Methamphetamine Addiction

Methamphetamine Use Disorder
Kevin Murnane20 enrolled1 locationNCT06899594
Recruiting
Not Applicable

Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder

Methamphetamine Use Disorder
University of Colorado, Denver20 enrolled1 locationNCT06320366
Recruiting
Not Applicable

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

Transcranial Magnetic StimulationMethamphetamine Use Disorder
Stanford University30 enrolled1 locationNCT06578429
Recruiting

Methamphetamine Cue-reactivity

Methamphetamine Use Disorder
Icahn School of Medicine at Mount Sinai88 enrolled1 locationNCT07086014
Recruiting
Phase 2

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Methamphetamine Use Disorder
Nicky Mehtani, MD, MPH12 enrolled1 locationNCT06538285
Recruiting

Role of Pavlovian Mechanisms for Control Over Substance Use

AlcoholismSubstance Use DisordersCannabis Use Disorder+4 more
Technische Universität Dresden200 enrolled1 locationNCT06701487
Recruiting
Not Applicable

Closed-loop cTBS for the Core Clinical Features of Methamphetamine Use Disorder

Amphetamine Use Disorders
Shanghai Mental Health Center30 enrolled1 locationNCT06457243